$104 Million is the total value of CAXTON CORP's 40 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 45.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MTEM | Buy | MOLECULAR TEMPLATES INC | $29,270,000 | +173.4% | 2,092,991 | +28.9% | 28.23% | +133.9% |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $13,819,000 | -12.6% | 6,612,065 | 0.0% | 13.33% | -25.2% | |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $12,974,000 | -0.7% | 659,252 | -24.3% | 12.51% | -15.1% |
| ABDC | Buy | ALCENTRA CAP CORP | $9,095,000 | +2.3% | 1,005,000 | +0.5% | 8.77% | -12.5% |
| SCYX | Buy | SCYNEXIS INC | $7,222,000 | +56.8% | 7,936,111 | +83.5% | 6.97% | +34.1% |
| GARRISON CAP INC | $7,118,000 | -15.8% | 1,223,096 | 0.0% | 6.86% | -28.0% | ||
| KALA | KALA PHARMACEUTICALS INC | $5,474,000 | -3.0% | 1,483,343 | 0.0% | 5.28% | -17.0% | |
| SPY | SPDR S&P 500 ETF TRtr unit | $4,509,000 | +8.4% | 14,010 | 0.0% | 4.35% | -7.3% | |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $2,747,000 | -28.6% | 8,134,926 | +52.2% | 2.65% | -38.9% |
| MEIP | MEI PHARMA INC | $2,097,000 | +47.6% | 845,560 | 0.0% | 2.02% | +26.3% | |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $925,000 | +45.4% | 62,096 | +0.1% | 0.89% | +24.4% |
| FSK | Buy | FS KKR CAPITAL CORP | $684,000 | +46.2% | 111,653 | +39.1% | 0.66% | +25.0% |
| CLMT | Buy | CALUMET SPECIALTY PRODS PTNRut ltd partner | $621,000 | +159.8% | 170,149 | +159.0% | 0.60% | +121.9% |
| CTIC | Buy | CTI BIOPHARMA CORP | $514,000 | +89.0% | 325,610 | +0.1% | 0.50% | +61.6% |
| CDLX | New | CARDLYTICS INC | $352,000 | – | 5,594 | +100.0% | 0.34% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $340,000 | – | 16,615 | +100.0% | 0.33% | – |
| ARQL | New | ARQULE INC | $310,000 | – | 15,522 | +100.0% | 0.30% | – |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $309,000 | +17.9% | 638 | +0.5% | 0.30% | +1.0% |
| KURA | Sell | KURA ONCOLOGY INC | $307,000 | -35.9% | 22,295 | -29.4% | 0.30% | -45.2% |
| TDG | Buy | TRANSDIGM GROUP INC | $290,000 | +7.8% | 518 | +0.4% | 0.28% | -7.6% |
| MA | Buy | MASTERCARD INCcl a | $286,000 | +10.0% | 959 | +0.3% | 0.28% | -5.8% |
| MELI | Buy | MERCADOLIBRE INC | $285,000 | +4.0% | 498 | +0.4% | 0.28% | -11.0% |
| MCO | Buy | MOODYS CORP | $280,000 | +16.2% | 1,179 | +0.3% | 0.27% | -0.7% |
| AMT | Buy | AMERICAN TOWER CORP NEW | $279,000 | +4.1% | 1,214 | +0.3% | 0.27% | -10.9% |
| V | Buy | VISA INC | $276,000 | +9.5% | 1,470 | +0.3% | 0.27% | -6.3% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $269,000 | +10.2% | 201 | +0.5% | 0.26% | -5.8% |
| FPAC | Buy | FAR PT ACQUISITION CORP | $263,000 | +0.8% | 25,569 | +0.1% | 0.25% | -13.6% |
| WWE | New | WORLD WRESTLING ENTMT INCcl a | $261,000 | – | 4,023 | +100.0% | 0.25% | – |
| CVNA | New | CARVANA COcl a | $255,000 | – | 2,770 | +100.0% | 0.25% | – |
| C | Buy | CITIGROUP INC | $249,000 | +16.4% | 3,111 | +0.3% | 0.24% | -0.4% |
| UAL | Buy | UNITED AIRLINES HLDGS INC | $244,000 | 0.0% | 2,772 | +0.3% | 0.24% | -14.5% |
| UNP | Buy | UNION PACIFIC CORP | $234,000 | +12.0% | 1,293 | +0.3% | 0.23% | -4.2% |
| GWRE | New | GUIDEWIRE SOFTWARE INC | $233,000 | – | 2,118 | +100.0% | 0.22% | – |
| LEN | Buy | LENNAR CORPcl a | $230,000 | +0.4% | 4,118 | +0.3% | 0.22% | -14.0% |
| RTN | New | RAYTHEON CO | $230,000 | – | 1,045 | +100.0% | 0.22% | – |
| WHR | New | WHIRLPOOL CORP | $223,000 | – | 1,509 | +100.0% | 0.22% | – |
| GM | Buy | GENERAL MTRS CO | $204,000 | -1.9% | 5,563 | +0.3% | 0.20% | -16.2% |
| HOME | New | AT HOME GROUP INC | $144,000 | – | 26,139 | +100.0% | 0.14% | – |
| GLYC | Sell | GLYCOMIMETICS INC | $136,000 | +18.3% | 25,748 | -3.1% | 0.13% | +0.8% |
| GSM | Buy | FERROGLOBE PLC | $124,000 | -16.2% | 131,426 | +0.0% | 0.12% | -28.1% |
| SBPH | Exit | SPRING BK PHARMACEUTICALS IN | $0 | – | -23,875 | -100.0% | -0.09% | – |
| UTX | Exit | UNITED TECHNOLOGIES CORP | $0 | – | -1,583 | -100.0% | -0.24% | – |
| JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -1,853 | -100.0% | -0.25% | – |
| IBKR | Exit | INTERACTIVE BROKERS GROUP IN | $0 | – | -4,098 | -100.0% | -0.25% | – |
| FWONK | Exit | LIBERTY MEDIA CORP DELAWARE | $0 | – | -5,386 | -100.0% | -0.25% | – |
| EXPE | Exit | EXPEDIA GROUP INC | $0 | – | -1,763 | -100.0% | -0.27% | – |
| CACC | Exit | CREDIT ACCEP CORP MICH | $0 | – | -517 | -100.0% | -0.27% | – |
| BRKB | Exit | BERKSHIRE HATHAWAY INC DELcl b new | $0 | – | -9,312 | -100.0% | -2.18% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -9,836 | -100.0% | -3.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLECULAR TEMPLATES INC | 24 | Q2 2023 | 30.7% |
| STRONGBRIDGE BIOPHARMA PLC | 22 | Q3 2021 | 73.1% |
| GARRISON CAP INC | 18 | Q3 2020 | 9.9% |
| BERKSHIRE HATHAWAY INC DEL | 17 | Q3 2019 | 5.8% |
| EIGER BIOPHARMACEUTICALS INC | 17 | Q3 2022 | 1.7% |
| AGILE THERAPEUTICS INC | 16 | Q1 2018 | 55.5% |
| KALA PHARNACEUTICALS INC | 16 | Q4 2021 | 17.6% |
| CM FIN INC | 16 | Q1 2019 | 7.8% |
| SYNTA PHARMACEUTICALS CORP | 15 | Q2 2016 | 99.9% |
| CTI BIOPHARMA CORP | 14 | Q4 2021 | 8.7% |
View CAXTON CORP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Addex Therapeutics Ltd. | February 14, 2023 | 718,849 | 0.9% |
| Cardiff Oncology, Inc. | February 14, 2023 | 983,607 | 2.2% |
| Rezolute, Inc. | February 14, 2023 | 1,860,518 | 5.0% |
| Xeris Biopharma Holdings, Inc. | February 14, 2023 | 5,973,324 | 4.4% |
| CTI BIOPHARMA CORP | February 14, 2022 | 2,239,300 | 2.3% |
| Sierra Oncology, Inc. | February 14, 2022 | 1,119,322 | 7.0% |
| Strongbridge Biopharma plcSold out | January 05, 2022 | 0 | 0.0% |
| SUNESIS PHARMACEUTICALS INCSold out | February 16, 2021 | 0 | 0.0% |
| Alcentra Capital Corp | February 14, 2020 | 1,005,000 | 7.8% |
| Garrison Capital Inc. | February 14, 2020 | 1,223,096 | 7.6% |
View CAXTON CORP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View CAXTON CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.